Compile Data Set for Download or QSAR
Report error Found 306 Enz. Inhib. hit(s) with all data for entry = 11106
TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590790BDBM590790(US11564928, Compound 37 | 6-(5-fluoropyridin-2-yl)...)
Affinity DataIC50: 0.600nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590808BDBM590808(US11564928, Compound 55 | 6-(5-(difluoromethoxy)py...)
Affinity DataIC50: 0.600nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590781BDBM590781(US11564928, Compound 28 | 6-(4-methoxyphenyl)-1-(2...)
Affinity DataIC50: 0.700nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590785BDBM590785(US11564928, Compound 32 | 6-(4-fluorophenyl)-1-(2-...)
Affinity DataIC50: 0.800nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590787BDBM590787(US11564928, Compound 34 | 1-(2-morpholinoethyl)-2-...)
Affinity DataIC50: 1nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590782BDBM590782(US11564928, Compound 29 | 6-(4-methoxyphenyl)-1-(2...)
Affinity DataIC50: 1.20nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590792BDBM590792(US11564928, Compound 39 | N-(4,4-dimethylcyclohexy...)
Affinity DataIC50: 1.20nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590783BDBM590783(US11564928, Compound 30 | N-(1-(4-fluorophenyl)eth...)
Affinity DataIC50: 1.20nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590780BDBM590780(US11564928, Compound 27 | N-(4,4-difluorocyclohexy...)
Affinity DataIC50: 2nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590804BDBM590804(US11564928, Compound 51 | 6-(4-(difluoromethoxy)ph...)
Affinity DataIC50: 2.10nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590779BDBM590779(US11564928, Compound 26 | N-(4,4-dimethylcyclohexy...)
Affinity DataIC50: 2.20nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590852BDBM590852(US11564928, Compound 102 | 1-(4-fluorobenzyl)-6-(o...)
Affinity DataIC50: 2.30nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590853BDBM590853(US11564928, Compound 103 | (R)-1-(4-fluorobenzyl)-...)
Affinity DataIC50: 3nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590846BDBM590846(US11564928, Compound 95 | (R)-N-(1-(4-cyanophenyl)...)
Affinity DataIC50: 3.20nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590844BDBM590844(US11564928, Compound 93 | 6-cyclopropyl-1-(4-fluor...)
Affinity DataIC50: 3.60nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590835BDBM590835(US11564928, Compound 84 | N-(bicyclo[1.1.1]pentan-...)
Affinity DataIC50: 3.70nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590786BDBM590786(US11564928, Compound 33 | 6-(2,3-dihydrobenzo[b][1...)
Affinity DataIC50: 4nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590850BDBM590850(US11564928, Compound 100 | (R)-N-(1-(4-fluoropheny...)
Affinity DataIC50: 4nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590845BDBM590845(US11564928, Compound 94 | (R)-6-cyclopropyl-1-(4-f...)
Affinity DataIC50: 4.10nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590803BDBM590803(US11564928, Compound 50 | N-(bicyclo[1.1.1]pentan-...)
Affinity DataIC50: 4.30nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590801BDBM590801(US11564928, Compound 48 | (R)-6-(5-(difluoromethox...)
Affinity DataIC50: 4.5nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590773BDBM590773(US11564928, Compound 20 | 4-hydroxy-6-(4-methoxyph...)
Affinity DataIC50: 4.70nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590789BDBM590789(US11564928, Compound 36 | 6-(5-cyanopyridin-2-yl)-...)
Affinity DataIC50: 5nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590838BDBM590838(US11564928, Compound 87 | (R)-6-bromo-1-(4-fluorob...)
Affinity DataIC50: 5nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590832BDBM590832(US11564928, Compound 81 | 6-bromo-1-(4-fluorobenzy...)
Affinity DataIC50: 5nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590811BDBM590811(US11564928, Compound 58 | 6-(5-cyanopyridin-2-yl)-...)
Affinity DataIC50: 5.58nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590799BDBM590799(US11564928, Compound 46 | N-(bicyc1o[1.1.1]pentan-...)
Affinity DataIC50: 6nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590759BDBM590759(US11564928, Compound 6 | 6-(4-fluorophenyl)-4-hydr...)
Affinity DataIC50: 6.10nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590758BDBM590758(US11564928, Compound 5 | 6-(4-fluorophenyl)-4-hydr...)
Affinity DataIC50: 6.5nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590839BDBM590839(US11564928, Compound 88 | (R)-1-(4-fluorobenzyl)-N...)
Affinity DataIC50: 6.70nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590793BDBM590793(US11564928, Compound 40 | 6-(5-cyanopyridin-2-yl)-...)
Affinity DataIC50: 7nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590842BDBM590842(US11564928, Compound 91 | (R)-6-bromo-N-(1-(4-cyan...)
Affinity DataIC50: 7nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590763BDBM590763(US11564928, Compound 10 | 4-hydroxy-6-(4- methoxy...)
Affinity DataIC50: 7nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590797BDBM590797(US11564928, Compound 44 | 6-(4-cyanophenyl)-1-(2-m...)
Affinity DataIC50: 7.20nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590788BDBM590788(US11564928, Compound 35 | 1-(2-morpholinoethyl)-2-...)
Affinity DataIC50: 7.5nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590851BDBM590851(US11564928, Compound 101 | (R)-N-(1-(4-cyanophenyl...)
Affinity DataIC50: 7.60nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590836BDBM590836(US11564928, Compound 85 | (R)-N-(1-(4-cyanophenyl)...)
Affinity DataIC50: 7.90nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590768BDBM590768(US11564928, Compound 15 | 6-(4-(difluoromethoxy)ph...)
Affinity DataIC50: 8.80nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590870BDBM590870(US11564928, Compound 121 | 6-(4-fluorophenyl)-4-hy...)
Affinity DataIC50: 9nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590805BDBM590805(US11564928, Compound 52 | 6-(4-(difluoromethoxy)ph...)
Affinity DataIC50: 10nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590841BDBM590841(US11564928, Compound 90 | (S)-6-bromo-1-(4-fluorob...)
Affinity DataIC50: 11nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590849BDBM590849(US11564928, Compound 99 | 6-bromo-1-((5-fluoropyri...)
Affinity DataIC50: 12nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590855BDBM590855(US11564928, Compound 105 | N-(4-fluorobenzyl)-6-(4...)
Affinity DataIC50: 14nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590886BDBM590886(US11564928, Compound 137 | 4-hydroxy-N-((1s,4s)-4-...)
Affinity DataIC50: 15nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590766BDBM590766(US11564928, Compound 13 | N-(bicyclo[1.1.1]pentan-...)
Affinity DataIC50: 17nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590761BDBM590761(US11564928, Compound 8 | N-(bicyclo[1.1.1]pentan-1...)
Affinity DataIC50: 20nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590772BDBM590772(US11564928, Compound 19 | 6-(2,3-dihydrobenzo[b][1...)
Affinity DataIC50: 20nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590769BDBM590769(US11564928, Compound 16 | 6-(4-cyanophenyl)-4-hydr...)
Affinity DataIC50: 22.6nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590795BDBM590795(US11564928, Compound 42 | 6-(5-cyanopyridin-2-yl)-...)
Affinity DataIC50: 23nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 590800BDBM590800(US11564928, Compound 47 | 6-(5-(difluoromethoxy)py...)
Affinity DataIC50: 24.9nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
US Patent

Displayed 1 to 50 (of 306 total ) | Next | Last >>
Jump to: